| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |